ILMN Illumina, Inc.
$276.03▲ +1.84%
Healthcare
Other
Volume 122.8K
Avg Volume (10D) 2.01M
Key Metrics & Fundamentals
Market Cap
$41.68B
P/E Ratio
51.2
Div Yield
0.00%
52W Range
94.00 - 309.35
% vs 50 MA
11.35%
% vs 200 MA
56.20%
RSI-14
55.5
MACD Histogram
-2.2600
Beta (1Y vs SPY)
0.81
Free Cash Flow
$251.00M
Gross Rev
$1.09B
Gross Profit
$721.00M
EBITDA
$250.00M
COGS
$370.00M
Operating Exp
$512.00M
Operating Income
$209.00M
EBIT
$209.00M
Pretax Income
$157.00M
Net Income
$134.00M
EPS (Diluted)
0.87
Price & Volume History
Loading chart…
Recent News
Global DNA Sequencing in Drug Discovery Market Report 2026 | Capitalize on 12.5% CAGR as Illumina, Thermo Fisher, QIAGEN, and Oxford Nanopore Accelerate AI-Driven Precision R&D
GlobeNewswire · Oct 26, 2026 10:36 AM ET
What Happens To Tempus AI Stock If Its Cash Burn Continues?
Trefis · Oct 26, 2026 8:47 AM ET
Should Illumina Stock Holders Look At Thermo Fisher Instead?
Trefis · Oct 23, 2026 1:36 PM ET
How Investors May Respond To Illumina (ILMN) BioInsight AI Rollout
Simply Wall St. · Oct 23, 2026 10:25 AM ET
NGS Kits Market Forecasts Growth from $6.84 Billion (2025) to $19.36 Billion by 2036, Profiling Illumina, Thermo Fisher Scientific, Roche, Oxford Nanopore & 11 Other Key Players
GlobeNewswire · Oct 23, 2026 10:05 AM ET
Stephens Downgrades Illumina to Equal Weight From Overweight, $275 Price Target
MT Newswires · Oct 23, 2026 9:33 AM ET
Twist Bioscience Sinks 9%, Illumina Down 5% as AI and Genomics Stocks Slide
TIKR · Oct 22, 2026 4:33 PM ET
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth
Zacks · Oct 22, 2026 9:00 AM ET
ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance
Zacks · Oct 22, 2026 7:45 AM ET
Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions?
Zacks · Oct 22, 2026 7:40 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2026
See ILMN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.